Actively Recruiting
Light Therapy for Obsessive-compulsive Disorder: A Circadian Medicine Approach
Led by Washington University School of Medicine · Updated on 2025-07-15
40
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating whether light therapy can reduce symptoms in young adults with obsessive-compulsive disorder (OCD) who have late bedtimes, specifically 1am or later. The study aims to understand if light therapy helps in reducing OCD symptoms and if it can advance the body's internal clock, known as the circadian clock. The trial compares a higher dose of light therapy to a lower dose to see if the amount of light affects symptom improvement. Participants will use wearable light therapy glasses that emit either a higher or lower intensity of light. They will wear these glasses for one hour each morning after waking up, continuing this routine for five weeks. The study groups include those receiving a higher light dose and those receiving a lower, sham dose. Additional assessments include a one-time test of sensitivity to light exposure. During the study, participants will track their sleep daily using a wearable monitor and an electronic sleep diary over five weeks. They will complete self-reported OCD symptom measures four times a day during specific periods: two weeks before treatment, one week mid-treatment, and one week at the end of treatment. Researchers will measure outcomes using the Yale Brown Obsessive-Compulsive Scale and daily perseverative thinking questionnaires, along with circadian melatonin levels at the start and end of the treatment period. The total study duration with assessments spans about seven weeks.
CONDITIONS
Brief Title
Light Therapy for Obsessive-compulsive Disorder (OCD)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Primary diagnosis of obsessive-compulsive disorder (OCD) according to DSM-5
- Usual bedtime of 1:00 AM or later
- Age between 18 and 35 years
- Able to speak English
You will not qualify if you...
- Currently participating in another research study that would affect participation
- Diagnostic or treatment status conflicts
- Working night shifts or traveling across more than one time zone outside Central Standard Time in the past month
- Pregnant
- Certain medication use
- Regular use of nicotine or marijuana
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 5 weeks
Participants receive light therapy using wearable devices for 1 hour each morning after awakening for 5 weeks.
3 visits (baseline, week 3, post-treatment)
Trial Site Locations
Total: 1 location
1
Washington University
St Louis, Missouri, United States, 63130
Actively Recruiting
Research Team
R
Rebecca Cox, BA
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here